Compare Cytokinetics Inc (CYTK) vs Enbridge Inc (ENB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Enbridge Inc — how do they compare? Cytokinetics Inc trades at $76.66 (market cap $10.78B), while Enbridge Inc trades at $51.67 (market cap $112.26B). The key difference: Enbridge Inc is far larger — about 10.4× Cytokinetics Inc's market cap, and Enbridge Inc pays a 5.36% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | ENB | |
|---|---|---|
Market Cap | $10.78B | $112.26B |
Sector | Technology | Energy |
52-Week High | $87.26 | $58.04 |
52-Week Low | $34.31 | $45.23 |
Enterprise Value | $10.88B | $196.07B |
Dividend Yield | — | 5.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cytokinetics (CYTK) trades at $76.76, down 5.67% today, with a bearish technical signal and negative profitability metrics. Recent Q2 2026 earnings beat EPS estimates but missed on revenue, while the company's drug Myqorzo shows strong commercial uptake and regulatory approvals in the UK. Cash flow remains negative from operations, offset by financing activities.
The outlook is mixed: strong analyst buy ratings (97%) and a $111.14 price target suggest upside, but high cash burn, competitive pressures, and lack of profitability pose significant risks. Investment appeal hinges on successful drug commercialization and path to profitability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →
